Hepatitis Vaccine Market – Analysis, Opportunities and Trends in the Global Industry, 2022-2028
![]() |
| Hepatitis Vaccine |
Hepatitis is an infectious condition brought
on by the hepatitis virus types A, B, and C. These viruses are responsible for
disorders related to the liver, including cirrhosis of the liver,
hepatocellular carcinoma, and liver failure. A person who is infected could die
from it. The hepatitis A and hepatitis B viruses are spread by contact with
bodily fluids of those who have the infection (blood, for example). Both
hepatitis A and hepatitis B can be prevented with hepatitis vaccines, boosting
immunity and preventing complications including cancer and liver failure. The
most susceptible group to infection is children. In the world, hepatitis B is
more prevalent than hepatitis A.
One of the most prevalent infectious diseases in the world,
hepatitis has caught the attention of medical organisations like the World
Health Organization due to its seriousness (WHO).
The Hepatitis
Vaccine Market is anticipated to grow as a result of the
increased prevalence of hepatitis around the world. The rising global
population is a further element driving the Hepatitis Vaccine Market expansion (live births). By 2025, the
population of the globe will increase to 9 billion people thanks to more live
births each year, predicts the 2017 World Population Report. In order to
protect newborns from hepatitis B infection, the WHO recommends that hepatitis
B immunisation be given within the first 24 hours of delivery. Additionally,
increasing public understanding of the benefits of hepatitis immunisation would
help the hepatitis vaccine industry develop its market. The global market for
hepatitis vaccines will grow as a result of the numerous companies releasing
vaccines to prevent hepatitis A and B.
An increase in public awareness about Hepatitis Infection prevention. Moreover, various governments
worldwide are introducing hepatitis vaccination programmes.
On the basis of
Indication
·
Hepatitis
A
·
Hepatitis
B
On the basis of Vaccine
Type
·
Recombinant
Vaccine
·
Inactivated
Vaccine
On the basis of
Distribution Channel
·
Hospitals
·
Retail
Pharmacy
·
Online
Pharmacy
Top Companies involved
are- Merck and
Company, GlaxoSmithKline, Sanofi Pasture, CSL Behring GmbH, Novartis AG and
Pfizer Inc. Few leading brands in hepatitis vaccine market are Engerix-B,
Havrix (Glaxosmithkline), Recombivax, Vaqta (Merck and Company), Euvax – Avaxim
(Sanofi Pasteur), and Shanvac B (Shantha Biotech)

Comments
Post a Comment